British singer Jessie J has said she’s been diagnosed with breast cancer. The star, 37, said that she will soon undergo surgery, though she was keen to stress that the cancer has been caught early.

Pop star Jessie J revealed she was diagnosed with “early breast cancer,” telling fans that she is going to “disappear for a bit” after her upcoming concert to undergo surgery.

Jessie J was diagnosed with "early breast cancer," the U.K. pop singer said on social media on Wednesday. The 37-year-old artist, whose real name is Jessica Ellen Cornish, said she was diagnosed ...

Jessie J is a mum and in a long term relationship with boyfriend Chanan Safir Colman, who is understood to be supporting her through this time. Here is all we know about him: ...

British pop star Jessie J has revealed she has been diagnosed with early breast cancer. The 37-year-old singer, whose real name is Jessica Ellen Cornish, said she had a surgery planned after the ...

“Harry Potter” author J.K. Rowling first came under fire for posting a series of controversial tweets about the transgender community in 2020.

Some pathological conditions affecting the human body can also disrupt metabolic pathways and thus alter the overall metabolic profile. Knowledge of metabolic disturbances in specific diseases could ...

DNA-encoded chemical library (DECL) screens are a rapid and economical tool to identify chemical starting points for drug discovery. As a robust transformation for drug discovery, palladium-catalyzed ...

Many viruses undergo large-scale conformational changes during their life cycles. Blocking the transition from one stage of the life cycle to the next is an attractive strategy for the development of ...

Galectin-3 is a β-galactoside-specific, carbohydrate-recognizing protein (lectin) that is strongly implicated in cancer development, metastasis, and drug resistance. Galectin-3 promotes migration and ...

Background Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid arthritis (RA).